This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Moriyuki Ohkuma: Innovator in Powdery Inhalational Preparations
Introduction
Moriyuki Ohkuma is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of dry powder inhalation systems. His innovative work aims to enhance the delivery and effectiveness of pharmaceutical active ingredients.
Latest Patents
Ohkuma holds a patent for "Powdery inhalational preparations and process for producing the same." This invention focuses on providing a dry powder inhalation with minimal adhesive-agglomerative properties during storage. It also ensures good inhalation behavior for pharmaceutically active ingredients. The dry powder inhalation involves adhering at least one active ingredient to the surface of a carrier particle made of erythritol and/or trehalose. Additionally, it includes formulations where S-36496 and/or Pralmorelin dihydrochloride are adhered to the carrier particle's surface. The invention also emphasizes improved taste during inhalation and reduced discomfort in the oral cavity and throat.
Career Highlights
Moriyuki Ohkuma is associated with Kaken Pharmaceutical Company, Ltd., where he continues to innovate in the pharmaceutical sector. His work has led to advancements in inhalation therapies, making them more effective and user-friendly.
Collaborations
Ohkuma has collaborated with notable colleagues, including Yoshiaki Kawashima and Yasutomi Kato. Their combined expertise has contributed to the success of various projects within the pharmaceutical industry.
Conclusion
Moriyuki Ohkuma's contributions to the field of inhalational preparations highlight his commitment to improving pharmaceutical delivery systems. His innovative approaches continue to influence the development of effective inhalation therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
